| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 117.21 | 6.1% | 15.9% |
| Total Income | 117.68 | 4.2% | 16.8% |
| Expenditure | 118.80 | 7.8% | 3.5% |
| PBT | -1.85 | 124.9% | 106.9% |
| Net Profit | -0.02 | 100.2% | 100.1% |
| OPM | 4.25% | 6.78pp | 7.37pp |
| NPM | -0.01% | 9.33pp | 14.51pp |
| EPS | 0.01 | 96.4% | 98.5% |
Sigachi Industries Q3 FY26 Results: Revenue at INR117.2 Crores, EBITDA at 4.6%
20 Feb 2026 · 20 Feb, 2:25 pm
Summary
Sigachi Industries Limited reported financial updates for Q3 & 9 Months FY26.
Key Highlights
- 1
rev: 117.2
- 2
ebitda: 5.7
- 3
ebitda margin: 4.6%
- 4
pat: -0.02
- 5
pat margin: (0.01%)
Management Comments
Amit Raj Sinha
From an operational standpoint, our plants are running at planned capacity, supply chains remain stable and customer demand continue to be strong. Today, our current cellulose-based excipient capacity stands at around 18,000 metric tons per annum with exports accounting for nearly 62% of production. Alongside operational stability, our focus on building a safer and more responsible organization remains central, and we continue to extend our support to affected families, while strengthening internal systems across the company. On the growth front, our capacity expansion plans continue to progress steadily. The 12,000 metric tons per annum MCC Dahej capacity expansion remains on track and once commissioned, our total cellulose-based excipient capacity is to touch 30,000 metric tons per annum with a commissioning target of Q3 FY27. In parallel, our 1,800 tons CCS disintegrant facility at Dahej SEZ is also progressing well and is expected to be commissioned in the same timeline of Q3 FY27. Supporting our portfolio and diversifying into high-value excipients. On the API side, we continue to strengthen our regulated market readiness through R&D and compliance-led initiatives. While our O&M vertical remains steady contributor and continues to evolve as a scalable services platform aligned with long-term growth priorities. As I conclude, I would like to reiterate that our operation remains stable and well managed and our ongoing projects continue to progress in line with plan. The action we have taken over the past few quarters have reinforced the resilience of our business and ensured that our long-term directions remain firmly on course. Looking ahead, we remain confident in our ability to deliver consistent and sustainable growth over the next two to three years, and of course, beyond that. Our excipient portfolio, expanding API initiatives and the O&M services business vertical together provide a diversified and balanced growth platform. With clear demand visibility and disciplined execution, we believe these businesses are well positioned to support steady value creation over the coming years. Our strategic priorities remain unchanged: expanding capacity, strengthening our product mix and improving profitability through operational excellence. Continued investment in quality systems, safety, compliance, R&D and infrastructure will remain central to this journey, ensuring that the growth is not only scalable, but also responsible and durable. The recent period has tested the organization in many ways, but it has also reaffirmed the strength of our teams. We responded with speed and responsibility, prioritized safety and business continuity and maintained momentum on our strategic initiatives. I would like to sincerely thank our employees, partners and shareholders for their continued trust and support. As we move forward, our focus remains firmly on safety, disciplined execution and long-term sustainable growth. With a clear roadmap and a committed team, we believe Sigachi is well positioned to emerge stronger and more resilient in the periods ahead.
Informational and educational content only. Not investment advice.